Neisseria Meningitidis Burden of Disease Study

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Streptococcus Pneumoniae; Neisseria Meningitidis; Haemophilus Influenzae

Treatments: Other: CSF samples testing; Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01730391

114989

Details and patient eligibility

About

This study aims to provide an estimate of the proportion of suspected cases of bacterial meningitis that are due to N. meningitidis and the serogroup responsible in The Philippines and Vietnam.

Enrollment: 521 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who the investigator believes can and will comply with the requirements of the protocol or subjects who the investigator believes that parent(s)/Legally Acceptable Representative(s) [LAR(s)] can and will comply with the requirements of the protocol.
• Written informed consent obtained from the subject/from the parent(s)/LAR of the subject.
• A male or female subject who visits the hospital with suspected bacterial meningitis.
• CSF sample taken as part of routine practice.

Exclusion criteria

• Child in care.

Trial design

521 participants in 1 patient group

Study cohort

Description:

Subjects visiting the hospital with suspected bacterial meningitis in The Philippines and Vietnam.

Treatment:

Other: Data collection

Other: CSF samples testing